NedaRasouliMD

Endocrinology • Aurora, CO

Diabetes, Lipid Metabolism

Associate Professor, Medicine, University of Colorado School of Medicine

Join to view full profile

Dr. Rasouli is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rasouli's full profile

Already have an account?

Office
12605 E 16th Ave
Aurora, CO 80045
Phone+1 720-848-0000

Education & Training

University of Arkansas for Medical Sciences (UAMS) College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2000 - 2002
Sparrow Hospital/Michigan State UniversityResidency, Internal Medicine, 1997 - 2000
Tehran University of Medical Sciences School of MedicineClass of 1995

Certifications & Licensure

CO State Medical License 2009 - 2025
AR State Medical License 2000 - 2010
MI State Medical License 2000 - 2001
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Most Compassionate Doctor American Registry

Clinical Trials

Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
Completed
Phase 3
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes Start of enrollment: 2013 May 01
Completed
Phase 3
Vitamin D and Type 2 Diabetes Study Start of enrollment: 2013 Oct 01
Completed
Not Applicable
Linagliptin Inpatient Trial Start of enrollment: 2014 Jan 01
Completed
Phase 4
The BROADEN Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Partial Lipodystrophy Start of enrollment: 2015 Dec 28
Terminated
Phase 2, Phase 3
A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin Start of enrollment: 2020 Oct 19
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Post Hoc Analysis of SURPASS-1 to -5: Efficacy and Safety of Tirzepatide in Adults with Type 2 Diabetes are Independent of Baseline Characteristics.
Christophe De Block, Jennifer Peleshok, John P H Wilding, Anita Y M Kwan, Neda Rasouli
Diabetes Therapy. 2024-11-12
Design and Baseline Characteristics of the STRIDE Trial: evaluating Semaglutide in People with Symptomatic Peripheral Artery Disease and Type 2 Diabetes.
Marc P Bonaca, Andrei-Mircea Catarig, Yasemin Hansen, Kim Houlind, Chethana Kalmady Ramesh
European Heart Journal. Cardiovascular Pharmacotherapy. 2024-10-18
1 citations
Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (G...
Kristina M Utzschneider, Naji Younes, Nicole M Butera, Ashok Balasubramanyam, Richard M Bergenstal
Diabetes Care. 2024-04-01

Journal Articles

Glycaemic Efficacy and Safety of Linagliptin Compared to Basal‐Bolus Insulin Regimen in Patients with Type 2 Diabetes Undergoing Non‐Cardiac Surgery: A Multicenter Ran...
Neda Rasouli, MD, Diabetes, Obesity and Metabolism

Press Mentions

The New Penicillin? Pharmacotherapy for ObesityNovember 19th, 2024
Given Shortages, Who ‘Deserves’ Ozempic and GLP-1 Drugs?August 10th, 2024
Research Helps Show Which Type 2 Diabetes Medication May Work BestJuly 23rd, 2024
Join now to see all

Grant Support

Effects Of Insulin Sensitizers And PPAR Ligands On Lipotoxicity In Subjects WithNational Center For Research Resources2006
Effects Of Insulin Sensitizers On Glucose And Fat Metabolism In Subjects With GENational Center For Research Resources2005–2006
Effects Of Insulin Sensitizers Of Beta Cell Function And LipotoxicityNational Center For Research Resources2005–2006
Pathophysiology Of Atypical Diabetes In African Americans: A Pilot ProposalNational Center For Research Resources2004
Insulin Sensitizers Of Beta Cell Function &LipotoxicityNational Center For Research Resources2004

Committees

member, Standards of Medical Care in Diabetes - 2015